Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 232,678,402 papers from all fields of science
Search
Sign In
Create Free Account
fosmidomycin
Known as:
3-(N-Hydroxyformamido)propylphosphonic acid
, (3-(formylhydroxyamino)propyl)phosphonic acid, monosodium salt
, 3-(N-hydroxyfomamido)propylphosphonate
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
5 relations
Broader (2)
Anti-Bacterial Agents
Fosfomycin
Narrower (2)
FR-31564
fosmidomycin monosodium salt
analogs & derivatives
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Synthesis of tetrazole analogues of phosphonohydroxamic acids: an attempt to improve the inhibitory activity against the DXR.
Anh‐Thu Nguyen‐Trung
,
D. Tritsch
,
C. Grosdemange-Billiard
,
M. Rohmer
Bioorganic & Medicinal Chemistry Letters
2013
Corpus ID: 22696156
2010
2010
Pharmacokinetics and metabolism of fosmidomycin, a new phosphonic acid, in rats and dogs
T. Tsuchiya
,
K. Ishibashi
,
M. Terakawa
,
M. Nishiyama
,
N. Itoh
,
H. Noguchi
European journal of drug metabolism and…
2010
Corpus ID: 26117918
SummaryThe absorption, distribution, metabolism, and excretion of 3-(N-formylhydroxylamino) propyl phosphonic acid monosodium…
Expand
2008
2008
Synthesis of beta- and gamma-oxa isosteres of fosmidomycin and FR900098 as antimalarial candidates.
T. Haemers
,
J. Wiesner
,
+7 authors
S. van Calenbergh
Bioorganic & Medicinal Chemistry
2008
Corpus ID: 25255728
To expand the structure-activity relationships of fosmidomycin and FR900098, two potent antimalarials interfering with the MEP…
Expand
2007
2007
Effect of fosmidomycin on metabolic and transcript profiles of the methylerythritol phosphate pathway in Plasmodium falciparum.
M. Cassera
,
E. Merino
,
Valnice J. Peres
,
E. Kimura
,
G. Wunderlich
,
A. Katzin
Memórias do Instituto Oswaldo Cruz
2007
Corpus ID: 25482349
In Plasmodium falciparum, the formation of isopentenyl diphosphate and dimethylallyl diphosphate, central intermediates in the…
Expand
2007
2007
Double Ester Prodrugs of FR900098 Display Enhanced In‐Vitro Antimalarial Activity
J. Wiesner
,
R. Ortmann
,
H. Jomaa
,
M. Schlitzer
Archiv der Pharmazie
2007
Corpus ID: 10300626
Fosmidomycin and FR900098 are inhibitors of the 1‐deoxy‐D‐xylulose 5‐phosphate reductoisomerase (DXR; IspC), a key enzyme of the…
Expand
2006
2006
Isoprenoid biosynthesis in plants – 2C‐methyl‐d‐erythritol‐4‐phosphate synthase (IspC protein) of Arabidopsis thaliana
F. Rohdich
,
S. Lauw
,
+4 authors
W. Eisenreich
The FEBS Journal
2006
Corpus ID: 31596214
The ispC gene of Arabidopsis thaliana was expressed in pseudomature form without the putative plastid‐targeting sequence in a…
Expand
2004
2004
Substrate analogs for the investigation of deoxyxylulose 5-phosphate reductoisomerase inhibition: synthesis and evaluation.
C. Phaosiri
,
P. Proteau
Bioorganic & Medicinal Chemistry Letters
2004
Corpus ID: 29420326
2003
2003
Methyl palmitate: a novel product of the Medfly (Ceratitis capitata) corpus allatum.
P. Moshitzky
,
I. Miloslavski
,
Z. Aizenshtat
,
S. Applebaum
Insect Biochemistry and Molecular Biology
2003
Corpus ID: 21087283
Highly Cited
2002
Highly Cited
2002
Isoprenoid Biosynthesis in Synechocystis sp. Strain PCC6803 Is Stimulated by Compounds of the Pentose Phosphate Cycle but Not by Pyruvate or Deoxyxylulose-5-Phosphate
Y. Ershov
,
R. Gantt
,
F. Cunningham
,
E. Gantt
Journal of Bacteriology
2002
Corpus ID: 8460526
ABSTRACT The photosynthetic cyanobacterium Synechocystis sp. strain PCC6803 possesses homologs of known genes of the non…
Expand
2002
2002
Genomics and global health
T. Pang
,
D. Weatherall
British medical journal
2002
Corpus ID: 37389635
The current revolution in genomics, culminating in the sequencing of the human genome, has tremendous potential to improve health…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE